Reasons for variation in transfusion practice in orthopedic surgery are not well understood. This systematic review identified and appraised the quality of the literature in this area to assess the impact of factors associated with the use of allogeneic red blood cell (RBC) transfusion in orthopedic procedures. MEDLINE and EMBASE databases were searched for relevant English language publications. Articles containing a range of MeSH and text terms regarding "blood transfusion," "predictors," and "multiple logistic regression" were retrieved. Articles that focused on patients undergoing orthopedic procedures and that met prespecified inclusion criteria were appraised in terms of potential bias and the appropriateness of statistical approach. A total of 3641 citations were retrieved, and 29 met the inclusion criteria for the review. Articles reported on a range of orthopedic procedures including total hip arthroplasty; total knee arthroplasty, total shoulder arthroplasty, and spinal surgery. Most studies were conducted in the United States (n = 12) or Canada (n = 5). Study quality was moderate; 50% or more of the quality criteria were assessed in 15 articles. Particular areas of concern were the lack of prospective studies, lack of clarity in defining the time interval between risk factor assessment and transfusion outcome, and lack of model validation. A narrative synthesis found that 2 factors consistently influenced the use of RBC transfusion-decreased hemoglobin (n = 25) and increased patient age (n = 18). Increased surgical complexity (n = 12), low body weight (n = 9), presence of additional comorbidities (n = 9), and female sex (n = 7) were also important factors. The general quality of the studies in the field is weak. However, low hemoglobin and increasing age were consistently identified as independent risk factors for RBC transfusion in orthopedic practice. Additional or alternative analytical approaches are required to obtain a more comprehensive, holistic understanding of the decision to transfuse RBCs to patients undergoing orthopedic surgery. © 2011 Elsevier Inc. All rights reserved.
O
RTHOPEDIC SURGERY ACCOUNTS for a considerable amount of red blood cells (RBCs) transfused. [1] [2] [3] Variation in the use of RBCs has been well documented in many specialties, [4] [5] [6] [7] [8] including orthopedics. [9] [10] [11] For example, Murphy et al 11 recently found that RBC use in patients undergoing primary total hip replacement in the UK ranged from 23% to 58%. Reasons for such variation are unclear and do not appear to be the result of case mix, surgical technique, or anesthetic practices. 7, 12 With concerns regarding the future supply of RBCs and transfusion safety, reducing variation in RBC use is of the utmost importance.
Transfusion guidelines have been produced in an attempt to standardize RBC use; these tend to set an upper threshold for hemoglobin of 10 g/dL, above which transfusion is not indicated, and a lower hemoglobin threshold of between 6 and 7 g/dL, below which transfusion is recommended. 13, 14 However, the evidence base for upper and lower hemoglobin transfusion thresholds is weak. 15 A review of the literature on transfusion triggers concluded that the limited evidence available supported the use of a restrictive transfusion threshold in patients without cardiac comorbidity. 16 A more recent trial found that there were no significant differences in postoperative ambulation, length of hospital stay, or achievement of independent ambulation between patients managed using liberal (10 g/dL) or restrictive (8 g/dL) RBC transfusion thresholds when undergoing hip fracture repair. Patients in the restrictive transfusion threshold group experienced significantly more cardiac events and higher mortality, however, the authors urged caution in interpretation because the study was not powered to investigate mortality and because there were significantly more patients with an American Association of Anesthesiologists (ASA) score of 3 in the restrictive group.
Furthermore, evidence to support practice within the "grey zone" between upper and lower transfusion thresholds where transfusion decisions are informed by other factors, for example, the presence of cardiovascular comorbidity or patient age, is lacking.
Because guideline implementation is highly dependent on the clinician's perceptions of the evidence base for guidelines, 18 deficiency in the evidence base and lack of consensus between guidelines are likely to contribute to the variation in practice observed.
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A better understanding of those factors that influence the need for RBC transfusion may facilitate better guideline development and transfusion decision making. A systematic review examined studies of the predictors of RBC transfusion in any clinical specialty. 22 Preoperative anemia, advanced age, female sex, and small body size were associated with an increased risk for transfusion. However, the review did not address the methodological quality of the studies included; the transfusion component considered as the outcome of interest varied across the studies; and the review did not discriminate between risk factors established through descriptive analysis, multiple linear regression analysis, or multiple logistic regression analysis. The latter is important because descriptive analyses do not account for the influence of other potential confounding factors that may lead to inaccurate results; multiple linear regressions examine factors associated with the number of units transfused, rather than the decision to transfuse itself, a question that requires the use of multiple logistic regression. Combining results from these different types of study is potentially misleading.
The aim of the systematic review reported here was to address these methodological shortcomings to provide an improved understanding of the factors influencing the decision to transfuse allogeneic RBCs in orthopedic practice.
METHODS

Search Strategy and Data Sources
The population, intervention, comparison, and outcome 23 criteria for the review were as follows: population of interest, adult patients, defined as 18 years or older, who had undergone an orthopedic procedure; intervention, allogeneic RBC transfusion in a hospital setting (inpatient/outpatient); comparison, patients who did not receive an allogeneic RBC transfusion; and outcomes, the patient, disease, and health service setting variables that may be associated with the use of allogeneic RBCs, as determined through multiple logistic regression methods.
Data sources and search terms. The electronic databases MEDLINE and EMBASE were searched using terms highlighted in Appendix 1 (available online). Searches were restricted to studies on humans, written in the English language, and on adult populations published between 1950 and August 2010. The reference sections of studies selected for full article review were hand searched for additional studies.
Study eligibility. The inclusion and exclusion criteria listed in Table 1 were applied. Articles with titles that appeared to meet the criteria for relevance, or that were ambiguous, went forward for abstract review. Articles with abstracts that appeared to meet the criteria or were ambiguous, or that had missing abstracts, were reviewed in full. At full article review, the articles that met the inclusion criteria were retained, and review data were extracted. An important inclusion criterion in the current review was the use of multiple logistic regression analyses. Multiple logistic regression is a common statistical method for assessing the association between a risk factor (eg, age, sex, hemoglobin) and an outcome (eg, probability of transfusion), while adjusting for potential confounding effects of other covariates. To avoid including studies that were likely to have produced a confounded estimate of an association between a risk factor and RBC transfusion, our review excluded those studies that did not use multiple logistic regression analysis.
Data extraction. Articles were reviewed and data extracted (Table 2 ) by two members of the research team (P.B. and K.B.) using a predesigned form. Where the information available to apply the inclusion criteria was ambiguous, a final decision was made by consensus within the study team.
Study Quality and Analysis
Study quality. A plethora of tools designed to assess study quality and scoring systems to summarize study quality have been created. 24, 25 Although there is no "gold standard method" or tool for assessing study quality, 25 two recent systematic reviews of critical appraisal tools for observational studies 25,26 provide some common themes among the many critical appraisal tools available. Guided by these reviews and materials from The Centre for Review and Dissemination, 27 The Critical Appraisal Skills Program, 28 the American Heart Association scientific statement "Standards for Statistical Models Used for Public Health Reporting of Health Outcomes," 29 and characteristics directed toward the statistical quality of the multiple logistic regression models, 30,31 we selected eight items with which to assess the quality of the included studies (Appendix 2, available online). Each item was assessed as either present (✓) or absent (✗). The higher the number of items assessed as "yes," the higher was the assumed quality of the study.
Data Analysis. The key characteristics of the studies and the quality of the studies were combined in a narrative summary and tabulated according to The Centre for Review and Dissemination guidelines (Appendices 2-4, available online).
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Source of Funding
The study was funded by the Research and Development Office of the Northern Ireland Health and Social Services.
RESULTS
Studies Selected
A total of 3641 citations were identified by the search strategy (Fig 1) . Of these, 264 abstracts were reviewed, and 69 met the criteria for full article review. After a hand search of the reference sections, a further 44 studies were added for full article review. To ensure that articles were not being rejected inappropriately, an abstract check was conducted on a sample of articles excluded on the basis of title only, and a full article check was conducted on a sample of articles excluded at abstract review. There were no articles that had their exclusion reversed by this process. A total of 29 studies met the inclusion criteria.
9,32-59 A description of each study and an assessment of study quality are provided in Table 2 and Appendix 2 (available online), respectively. Due to the differences between studies, in terms of the patient population studied and the risk factors included in the regression models, ( Table 2 and Appendix 3. available online), a meta-analysis was not considered to be appropriate. A detailed narrative summary was the most pragmatic method to provide a meaningful description and appraisal of the literature.
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Description of Studies
The 29 studies that met the inclusion criteria concerned patients undergoing one of the following orthopedic procedures: total hip arthroplasty (THA) and total knee arthroplasty (TKA) 35 Adult humans undergoing an orthopedic procedure.
Patients under the age of 18 y. The decision to prescribe an allogeneic RBC transfusion occurred within a hospital setting (inpatient/outpatient).
The decision to prescribe an allogeneic RBC transfusion occurred outside the hospital or orthopedic setting (eg, general practice, home transfusion, or other specialty). The RBC transfusion was not allogeneic in nature (eg, autologous blood use), or if the outcome was a combination of all blood products transfused.
(such as fresh frozen plasma, platelets and cryoprecipitate).
Multiple logistic regression analysis was used to determine the influence of the risk factors on the likelihood of receiving an allogeneic RBC transfusion.
A multiple logistic regression model was not used to determine predictors of transfusion.
Primary research (the authors have conducted the study as an original piece of primary research).
The outcome of interest was massive transfusion (eg, predicting the need for ≥3 units of allogeneic RBCs). The study was not a primary piece of research; for example, letters, reviews, or editorials would be excluded.
Italy, 37 Holland, 51 Japan, 40 and Spain. 56 One study was conducted across Ireland and Scotland. 43 The median proportion of patients transfused was 24.5% (range, 7.5%-51.9%). The percentage of transfused patients within each of the categories of surgical procedure varied: 9.7% to 39.5% (THA/ TKA), 16% to 49.9% (THA alone), 15.8% to 47.6% (THA alone with fracture), 7.5% to 51.9% (TKA only), 19.6% to 43% (TSA), and 19% to 32% (spinal surgery). Several studies included patients who were enrolled in an autologous transfusion program but who had also received an allogeneic transfusion. 35, 36, 41, 44, 45, 47, 48, 59, 62 In these cases, the percentage of patients transfused allogeneic RBCs was much lower, from as little as 7.5% 47 to 37%. 35 The median age of the patients studied was 67 years (range, 53-83 years), and the median proportion of male patients was 41% (range, 23%-82%). The youngest patients were those undergoing spinal surgery, with the oldest being those admitted with hip fracture. Two of the 4 studies including hip fracture admissions were restricted to patients of 60 years or older.
The time frame during which factors associated with transfusion were assessed included the perioperative (n = 14) 9 
Study Quality
Only 15 of the studies assessed 50% or more of the predefined study quality items 9,32-34,37,39,43,49,52-55,57-59 (Appendix 2, available online). Most studies were retrospective case series, with a relative dearth of prospective studies (item 3). There was a lack of clarity in defining the time interval between risk factor assessment and transfusion outcome (item 5) and limited attempts at validation of statistical models (item 8).
In the few studies that attempted to validate their statistical model, the performance of the models in predicting the need for transfusion was relatively poor. For example, Feagan et al 39 found that their model had a poor specificity, 22.8%, which decreased in the validated model to 21.3%, although the sensitivity of their model was more than 90%.
Risk Factors Identified
The studies reported a median of four independent risk factors (range, 1-13) that were associated with the risk of receiving an RBC transfusion. The reported odds of receiving an RBC transfusion varied dramatically between studies (Appendix 3, available online).
Decreasing hemoglobin and older age were the most common associated factors. Hemoglobin remained in the final adjusted model in the majority of studies where it was considered 9 46 and metastases. 34 An ASA physical status classification of 3 (indicating severe systemic disease) or greater was also found to be a risk factor impacting on transfusion decision making in one study. 54 One study did not have any of the aforementioned variables in the adjusted model. This study was investigating the potential link between serotonergic antidepressants and transfusion risk. Despite collecting information on hemoglobin, this variable did not appear in the analysis presented, and no explanation for this decision was offered. 51 Fourteen studies mentioned explicitly that transfusion criteria were used to guide transfusion decisions (Appendix 4, available online). 59 The main transfusion criterion in these cases was the hemoglobin level. The precise hemoglobin threshold for transfusion was modulated by the presence of symptoms of anemia, when a higher hemoglobin threshold ranging from 8.5 to 
NOTE. U , Present; C , absent; N, not considered in model; N/S, not stated; Hb, hemoglobin; TKA, total knee arthroplasty; THA, total hip arthroplasty; PAD, pre-operative autologous donation; op, operative; DHS, deep hip screw; n = number of patients analyzed.
⁎ Unilateral & bilateral procedures analyzed separately: Female only a factor in Unilateral analysis.
TRANSFUSION DECISION-MAKING IN ORTHOPEDIC SURGERY
12 g/dL was deemed appropriate, whereas in the absence of symptoms, the acceptable hemoglobin was between 6 and 9 g/dL. Several of the authors mentioned that the criteria were for guidance only and that the transfusion decision was down to the clinician. 36 ,41,42,52,59
DISCUSSION
The current systematic review is the first to investigate the predictors of RBC transfusion in orthopedic practice. Despite the presence of marked heterogeneity among the included studies with regard to patient populations, surgical procedures, study design, and study quality, it was possible to discern some common themes using a narrative approach.
There was marked variation in the proportion of patients transfused, some of which could be explained by differences in case mix and the nature of the surgical procedures studied. For example, the lowest percentage of patients transfused (9.7%) was observed in the subgroup of studies focusing on THA/TKA; however, these patients were also included in an aggressive autotransfusion program. 37 In two other studies with low transfusion rates, preoperative autologous donation (PAD) was also offered at the study centers, which may have contributed to the lower rates of allogeneic RBC transfusion observed. High rates of transfusion (N40%) were observed in two studies involving patients undergoing THA for hip fracture 33,63 that included only patients older than 60 years. Increased complexity of surgery may be related to an increase in the amount of surgical bleeding and therefore exposure to transfusion risk. 9 ,32,44,52
The use of clinical transfusion guidelines may be expected to reduce variation; however, differences between guidelines and variable implementation could have the opposite effect. The acceptable hemoglobin threshold for transfusion that is recommended for otherwise healthy patients is between 6 and 7 g/dL. However, hemoglobin on its own may be a poor indicator of tissue hypoxia, 64 and current thinking suggests that each individual patient has an "acceptable" hemoglobin level, and it is this that should be maintained through transfusion. Given this complexity, the absence of a consistent relationship between the presence of liberal or restrictive guidelines and the proportion of patients transfused (Appendix 4, available online) is not surprising.
The observation that reduced hemoglobin, older age, and low body weight are influential drivers of transfusion decision making in an orthopedic setting is in keeping with the findings reported from other clinical specialties.
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Because the transfusion of RBCs will increase hemoglobin levels, a lower level of hemoglobin, or anemia, would be expected to be a key risk factor for RBC transfusion.
22, 65 The older patients are less likely to tolerate a lower hemoglobin and hematocrit 13 and are therefore more likely to benefit from RBC transfusion. Furthermore, some of the risks associated with transfusion, such as transfusiontransmitted infection, have long latent periods and may therefore be of lesser importance in assessing the balance of risks and benefit in the older patients. For younger patients, the avoidance of transfusion because of the potential longer term risks may outweigh any short-term benefit of the transfusion in some circumstances.
66
Lower body weight is associated with a smaller RBC volume, 22,67 and therefore lighter patients may be less able to compensate for blood loss.
22
Female sex appeared less influential than suggested in previous studies, 22,68 being found to be a risk factor for transfusion in only seven studies included in the current review. Because females tend to be lighter than males, the influence of sex may be partly explained by the relationship of weight/blood volume to the risk of transfusion as well as the tendency for females to have lower baseline hemoglobin than males.
Our review also found that the comorbidity was associated with an increased risk for transfusion. Although specific comorbidities varied, they appeared to be linked by the common theme of reduced capacity to tolerate anemia.
Overall, the assessed quality of articles in the current review was not high and potentially limits the strength of the findings. However, a limitation when making any quality assessment is the availability of relevant information in the published article; where such information is missing, studies may be misclassified with respect to quality. Study quality was not one of the inclusion or exclusion criteria for the current review but was viewed as an aid to understanding the methods of studies included in the review and their impact on the data obtained and the conclusions drawn. However, regardless of quality of the study, there did not appear to be a difference in findings. Yet, it is difficult to disentangle the impact of quality on the studies, from other factors that may have also affected study outcomes, for example, patient populations, study size, study setting, and guideline use.
The items that were used to assess the quality of the studies have not been validated as a stand-alone quality appraisal tool. However, the items were based on previously validated measures identified via a systematic review of tools used to assess the quality of appraisal tools [25] [26] [27] [28] and covered the key areas of quality appraisal and specific items pertinent to the type of articles reviewed, such as selection bias (items 1 and 2) and statistical quality (items 6-8) as itemized in Appendix 2 (available only online).
The quality assessment revealed a lack of prospective studies and of model validation. Furthermore, many investigators failed to define the time period between risk factor assessment and transfusion outcome. The latter is an important design issue, because any relationship found between a risk factor and transfusion that infers importance in decision making means that the information on the "risk factor" must be relevant and available at the time the decision is taken. For example, admission hemoglobin may not be the most relevant hemoglobin measurement to consider in the context of postoperative transfusion. Authors investigating the risk for transfusion among cardiac patients have also highlighted this issue. 12 Although statistical modeling is useful in identifying some factors and their relative impact on the decision to transfuse, there are other factors that cannot be as readily accommodated within a statistical model because they are difficult to assess or measure, for example, physician beliefs and personality. 9 These factors may be particularly influential when the decision to transfuse is within the gray zone of hemoglobin, between 7 and 10 g/dL. The application of qualitative research methods to identify such drivers of transfusion practice or the use of heuristics in transfusion decision making are attractive options for further investigation of this issue. 69 A meta-analysis was not possible because of the aforementioned heterogeneity among study populations and study design as well as the failure to present odds ratios (ORs) in the published articles. Furthermore, where ORs were presented, the variation in the number and type of factors included and how they were incorporated in the models influenced the actual figure reported (Appendix 3, available online).
CONCLUSIONS AND RECOMMENDATIONS
Although the variable design and quality of studies conducted in this area of practice precluded the conduct of a meta-analysis, this narrative review has confirmed that hemoglobin, age, and weight are independent risk factors for transfusion of RBC. In addition, comorbidity leading to a reduction in the capacity to tolerate anemia and complexity of the surgical procedure undertaken are also identified as risk factors for RBC transfusion in the orthopedic setting.
To improve the evidence base for RBC transfusion guidelines and practice, we suggest that future research attempts to capture additional factors that may influence clinical decision making but that cannot be readily categorized and included in a statistical model, by using a qualitative approach. 27. Centre for Reviews and Dissemination: Undertaking systematic reviews of research on effectiveness: CRD's guidance for those carrying out or commissioning reviews. 4 
Were response rates reported and explained (follow-up of patients)?
3. Was the data on the risk factors collected prospectively?
4. Did the study report methods and procedures, which indicate good quality data collection of risk factors?
5. Was the time interval between risk factor measurement and transfusion outcome clearly defined?
Were there a sufficient number of events per variable included in the model?
Were the ORs and confidence intervals of the significant risk factors in the final adjusted model provided?
Was validation of the model also considered? 
Was the data on the risk factors collected prospectively?
Was validation of the model also considered?
NOTE. U , present; C, absent/not enough information in the study to determine. 
